Literature DB >> 12938722

Thyroid cancers in France and the Chernobyl accident: risk assessment and recommendations for improving epidemiological knowledge.

P Verger1, O Catelinois, M Tirmarche, L Chérié-Challine, Ph Pirard, M Colonna, Ph Hubert.   

Abstract

From 1975 to 1995, the incidence of thyroid cancer in the French population increased by a factor of 5.2 in men and 2.7 in women, thereby raising public concerns about its association with the nuclear accident at Chernobyl. A study performed at the request of French health authorities sought to quantify the potential risk of thyroid cancer associated with the Chernobyl fallout in France in order to determine if this risk could be observed through an epidemiological approach. The study focused on the most exposed population: those living in eastern France and younger than 15 y at the time of the Chernobyl nuclear power plant accident (26 April 1986). The number of spontaneous thyroid cancers in this population was predicted from French cancer registry data, and the thyroid doses were estimated from all available data about contamination in France. Associated risks were calculated with different risk models, all based on a linear no-threshold dose-effect relationship. Under this hypothesis, from 1.3 to 22 excess thyroid cancer cases were predicted for the 1991-2000 period, compared with the 212 spontaneous cases (0.5 to 10.5%) predicted, and from 11.2 to 55.2 excess cases were predicted for 1991-2015, compared with the 1,342 spontaneous cases (0.8 to 4.1%) predicted. These risk calculations indicate that the Chernobyl fallout cannot explain the entire increase in thyroid cancers in France, and that it is improbable that an epidemiological study could demonstrate such an excess. The surveillance of thyroid cancers in France should be enhanced.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12938722     DOI: 10.1097/00004032-200309000-00008

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  6 in total

1.  Thyroid cancer incidence in Ukraine: trends with reference to the Chernobyl accident.

Authors:  M Fuzik; A Prysyazhnyuk; Y Shibata; A Romanenko; Z Fedorenko; L Gulak; Y Goroh; N Gudzenko; N Trotsyuk; O Khukhrianska; V Saenko; S Yamashita
Journal:  Radiat Environ Biophys       Date:  2010-11-10       Impact factor: 1.925

Review 2.  Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma.

Authors:  Geoffrey B Thompson; Ian D Hay
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

3.  Dietary habits during the 2 months following the Chernobyl accident and differentiated thyroid cancer risk in a population-based case-control study.

Authors:  Constance Xhaard; Carole Rubino; Vincent Souchard; Stéphane Maillard; Yan Ren; Françoise Borson-Chazot; Geneviève Sassolas; Claire Schvartz; Marc Colonna; Brigitte Lacour; Anne Sophie Woronoff; Michel Velten; Emilie Marrer; Laurent Bailly; Eugènia Mariné Barjoan; Martin Schlumberger; Vladimir Drozdovitch; Andre Bouville; Jacques Orgiazzi; Elisabeth Adjadj; Florent de Vathaire
Journal:  Cancer Epidemiol       Date:  2018-01-08       Impact factor: 2.890

4.  Prevalence of thyroid nodules in an occupationally radiation exposed group: a cross sectional study in an area with mild iodine deficiency.

Authors:  Paolo Trerotoli; Anna Ciampolillo; Giuseppe Marinelli; Riccardo Giorgino; Gabriella Serio
Journal:  BMC Public Health       Date:  2005-07-07       Impact factor: 3.295

5.  Thyroid cancer in Luxembourg: a national population-based data report (1983-1999).

Authors:  René Scheiden; Marc Keipes; Carlo Bock; Walter Dippel; Nelly Kieffer; Catherine Capesius
Journal:  BMC Cancer       Date:  2006-04-24       Impact factor: 4.430

6.  Association between the increase in incidence of papillary thyroid carcinoma in Crete and exposure to radioactive agents.

Authors:  E P Prokopakis; A Kaprana; A Karatzanis; G A Velegrakis; J Melissas; G Chalkiadakis
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-02-28       Impact factor: 2.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.